Top 10 Emerging Pharmaceutical Companies in the US in 2021 by Revenues

Organon & Co, Emergent BioSolutions Inc, OPKO Health Inc, United Therapeutics Corp, and Vir Biotechnology Inc are the top 5 emerging pharmaceutical companies in the US in 2021 by revenue. Cumulatively, the top 10 emerging pharmaceutical companies in the US employed a total of 14,626 people in 2021. Organon & Co (Organon) is the leading emerging pharmaceutical company in the US in 2021 by revenue. The company discovers and develops biosimilars and medicines. It provides medicines and solutions for various conditions including respiratory, cardiovascular, dermatology, non-opioid pain, women’s health, and others. The company’s products include mometasone furoate inhalation powder, follitropin beta injection, alendronate sodium, acetate injection, chorionic gonadotropin, and others. It conducts patient assistance and an Organon access program, which provides free medicines to individuals. The company reported revenues of $6,174 million for the fiscal year ended December 2022 (FY2022), a decrease of 2.06% over the previous year. Emergent BioSolutions Inc is one of the emerging pharmaceutical companies in the US in 2021 by revenue. It is a life sciences company that provides specialized products to address medical needs and public health threats (PHTs). Its solutions help address PHTs including chemical, biological, radiological, nuclear, and explosives (CBRNE), emerging infectious diseases, travel health, emerging health crises, and acute/emergency care. The company reported revenues of $1,121 million for the fiscal year ended December 2022 (FY2022), a decrease of 37.47% over the previous year. It operates through a single reportable segment and recognizes revenue through three categories, namely, Product Sales, Contract Development and Manufacturing (CDMO) services, and Contracts and Grants with 2,416 employees.